Protein kinase CK2 inhibition suppresses neointima formation via a proline-rich homeodomain-dependent mechanism.

about

CX-4945 Induces Methuosis in Cholangiocarcinoma Cell Lines by a CK2-Independent Mechanism

P2860

Q58710589-E1977497-B903-45CB-896D-A184AB75F8F5

P2860

Protein kinase CK2 inhibition suppresses neointima formation via a proline-rich homeodomain-dependent mechanism.

Item

http://www.wikidata.org/entity/Q47150236

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Protein kinase CK2 inhibition ...... meodomain-dependent mechanism.

@en

Protein kinase CK2 inhibition ...... meodomain-dependent mechanism.

@nl

type

Item

label

Protein kinase CK2 inhibition ...... meodomain-dependent mechanism.

@en

Protein kinase CK2 inhibition ...... meodomain-dependent mechanism.

@nl

prefLabel

Protein kinase CK2 inhibition ...... meodomain-dependent mechanism.

@en

Protein kinase CK2 inhibition ...... meodomain-dependent mechanism.

@nl

P1476

Protein kinase CK2 inhibition ...... omeodomain-dependent mechanism

@en

P2093

B A Brown

http://www.w3.org/2001/XMLSchema#string

G B Sala-Newby

http://www.w3.org/2001/XMLSchema#string

K S Wadey

http://www.w3.org/2001/XMLSchema#string

P2860

HEX acts as a negative regulator of angiogenesis by modulating the expression of angiogenesis-related gene in endothelial cells in vitro

A CK2-dependent mechanism for degradation of the PML tumor suppressor

CK2 phosphorylation of the PRH/Hex homeodomain functions as a reversible switch for DNA binding

Misregulation of the proline rich homeodomain (PRH/HHEX) protein in cancer cells and its consequences for tumour growth and invasion

A null mutation of Hhex results in abnormal cardiac development, defective vasculogenesis and elevated Vegfa levels

Homeobox protein Hex induces SMemb/nonmuscle myosin heavy chain-B gene expression through the cAMP-responsive element

The selectivity of inhibitors of protein kinase CK2: an update.

Protein kinase CK2: structure, regulation and role in cellular decisions of life and death.

A biodegradable perivascular wrap for controlled, local and directed drug delivery.

Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.

P304

34-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VPH.2017.09.004

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kevin Gaston

Sarah J George

Padma-Sheela Jayaraman

P577

2017-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28927755

http://www.w3.org/2001/XMLSchema#string

P932

5718878

http://www.w3.org/2001/XMLSchema#string

Protein kinase CK2 inhibition suppresses neointima formation via a proline-rich homeodomain-dependent mechanism.

about

P2860

P2860

Protein kinase CK2 inhibition suppresses neointima formation via a proline-rich homeodomain-dependent mechanism.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932